Entity

Regeneron Pharmaceuticals

American pharmaceutical company

Express your sentiment! Sign in!
Entity sentiment
1
Business
Regeneron buys 23andMe's assets for $256 million after bankruptcy
Regeneron Pharmaceuticals 23andMe
Other
Regeneron is accused of fraudulent price reporting for eye drug
Regeneron Pharmaceuticals United States Department of Justice
You've reached the end